First Time Loading...

Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

Watchlist Manager
Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Watchlist
Price: 2 307.25 INR -1.83%
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one LALPATHLAB stock under the Base Case scenario is 2 583.61 INR. Compared to the current market price of 2 307.25 INR, Dr. Lal PathLabs Ltd is Undervalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LALPATHLAB Relative Value
Base Case
2 583.61 INR
Undervaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.9
P/S
P/S
Price to Sales
8.9
vs History
71
vs Industry
15
Median 3Y
9.9
Median 5Y
9.9
Industry
2.4
Forward
8.4
More Details
58.9
P/E
P/E
Price to Earnings
58.9
vs History
69
vs Industry
7
Median 3Y
69.6
Median 5Y
68.1
Industry
23.2
Forward
52.8
More Details
37.4
P/OCF
P/OCF
Price to OCF
37.4
vs History
71
vs Industry
10
Median 3Y
43.9
Median 5Y
42.8
Industry
15.5
More Details
63.4
P/FCFE
P/FCFE
Price to FCFE
63.4
vs History
69
vs Industry
9
Median 3Y
75.5
Median 5Y
72.7
Industry
23.5
More Details
11
P/B
P/B
Price to Book Value
11
vs History
74
vs Industry
6
Median 3Y
12.7
Median 5Y
12.3
Industry
2.2
More Details
8.6
EV/S
EV/S
Enterprise Value to Sales
8.6
vs History
69
vs Industry
15
Median 3Y
9.5
Median 5Y
9.4
Industry
2.5
Forward
8.1
More Details
10.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.9
vs History
73
vs Industry
20
Median 3Y
12.4
Median 5Y
12
Industry
5.2
More Details
32.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
32.3
vs History
80
vs Industry
8
Median 3Y
37.4
Median 5Y
38.4
Industry
12.5
Forward
29.6
More Details
43.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
43.1
vs History
69
vs Industry
8
Median 3Y
49.8
Median 5Y
48.2
Industry
17.2
Forward
39.5
More Details
36.1
EV/OCF
EV/OCF
Enterprise Value to OCF
36.1
vs History
71
vs Industry
10
Median 3Y
42.4
Median 5Y
41.3
Industry
15.1
More Details
39.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
39.4
vs History
52
vs Industry
14
Median 3Y
39.9
Median 5Y
39.9
Industry
19.7
More Details
14.2
EV/IC
EV/IC
Enterprise Value to IC
14.2
vs History
68
vs Industry
5
Median 3Y
14.2
Median 5Y
24.6
Industry
2
More Details

Multiples Across Competitors

LALPATHLAB Competitors Multiples
Dr. Lal PathLabs Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
191.8B INR 8.9 58.9 32.3 43.1
US
Cigna Group
XMUN:CGN
98.9B EUR 0.5 20.5 10.5 14
US
Cigna Corp
NYSE:CI
100.8B USD 0.5 19.5 10.1 13.4
US
CVS Health Corp
NYSE:CVS
71B USD 0.2 8.5 7.8 7.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8B EUR 0.7 -26.5 10.1 22.6
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD 1.4 39 11.9 17.9
US
Quest Diagnostics Inc
NYSE:DGX
15.1B USD 1.6 18 10.8 14.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR 0.6 23.6 7 16.5
US
DaVita Inc
NYSE:DVA
12.6B USD 1 18.3 8.7 12.8
DE
Fresenius Medical Care AG
XMUN:FME
11.5B EUR 0.6 23.1 6.9 16.3
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
LALPATHLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
LALPATHLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LALPATHLAB stock valuation using valuation multiples.
Wall Street Estimates
LALPATHLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LALPATHLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.